Skip to content

Drug interactions

Posaconazole + Tofacitinib

Severity: Major

Posaconazole and Tofacitinib: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Posaconazole is a potent CYP3A4 inhibitor and raises tofacitinib exposure. This increases the risk of infection, cytopenias and other dose-related adverse effects.

What this interaction means in plain words

Posaconazole and Tofacitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Posaconazole belongs to Anti Fungals; Tofacitinib belongs to Musculoskeletal.

Evidence level: Moderate

Why it happens

Potent CYP3A4 inhibition reduces tofacitinib clearance.

What to do

Reduce the tofacitinib dose per labeling (for example, once daily when on 5 mg twice daily). Monitor for infection and blood count changes.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Posaconazole and Tofacitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Posaconazole with Tofacitinib?

MediHelp rates the interaction as major. Posaconazole and Tofacitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Posaconazole is a potent CYP3A4 inhibitor and raises tofacitinib exposure. This increases the risk of infection, cytopenias and other dose-related adverse effects.

How serious is the interaction between Posaconazole and Tofacitinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reduce the tofacitinib dose per labeling (for example, once daily when on 5 mg twice daily). Monitor for infection and blood count changes.

What other medicines interact with Tofacitinib?

MediHelp also lists interactions of Tofacitinib with, for example, Baricitinib, Cladribine, Upadacitinib. The full list is on the Tofacitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in